compounding pharmacies
The latest news about compounding pharmacies: headlines, AI summaries and the full story from every source.
- Hims & Hers Health Shares Rise Following HHS Announcement on Peptide Compounding
- Trump administration reportedly considering temporary sale of unapproved peptides
- FDA Panel Recommends Four Peptides for Inclusion on Compounding List
- FDA Begins Review of Restricted Peptide Compounds, Boosting Hims & Hers Shares
- Hims & Hers stock rises on FDA signals of relaxed peptide restrictions